Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Four countries to boycott Eurovision 2026 over Israel’s inclusion - 2Gov’t approves millions for border cities in North under Hezbollah fire
- 3Vial marked 'Polonium 210' sparks scare during German Easter egg hunt
- 4Flu activity rises sharply across US with 7.5 million cases, CDC data shows
- 515 skywatching events you won't want to miss in 2026
- RFK Jr. succeeds in changing hepatitis B recommendation | The Excerpt
- The Manual for Electric Vehicles that will be hot dealers in 2023
- Giant ‘toothed’ birds flew over Antarctica 40 million to 50 million years ago
- CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation
- New COVID-19 variant 'Cicada' is spreading. What to know about BA.3.2.
- Israel strikes Iranian nuclear development facilities, Tehran vows retaliation
- Millions in JDM Exports and Exotic Supercars Are Currently Trapped at Sea
- Sally Rooney books may be withdrawn from UK sale over Palestine Action ban, court told
- Hubble Space Telescope spies dusty debris from two cosmic collisions
